Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Current Leases (2020 - 2023)

Historic Current Leases for Q32 Bio (QTTB) over the last 4 years, with Q4 2023 value amounting to $1.3 million.

  • Q32 Bio's Current Leases fell 1556.69% to $1.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year decrease of 1556.69%. This contributed to the annual value of $1.3 million for FY2023, which is 1556.69% down from last year.
  • Per Q32 Bio's latest filing, its Current Leases stood at $1.3 million for Q4 2023, which was down 1556.69% from $1.8 million recorded in Q3 2023.
  • In the past 5 years, Q32 Bio's Current Leases registered a high of $2.5 million during Q4 2020, and its lowest value of $246000.0 during Q4 2021.
  • Moreover, its 4-year median value for Current Leases was $1.7 million (2023), whereas its average is $1.7 million.
  • As far as peak fluctuations go, Q32 Bio's Current Leases plummeted by 9016.39% in 2021, and later surged by 53455.28% in 2022.
  • Over the past 4 years, Q32 Bio's Current Leases (Quarter) stood at $2.5 million in 2020, then crashed by 90.16% to $246000.0 in 2021, then soared by 534.55% to $1.6 million in 2022, then dropped by 15.57% to $1.3 million in 2023.
  • Its last three reported values are $1.3 million in Q4 2023, $1.8 million for Q3 2023, and $1.7 million during Q2 2023.